BioCentury
ARTICLE | Clinical News

MyoCell: Phase III started

July 15, 2013 7:00 AM UTC

Bioheart began the double-blind, placebo-controlled, North and South American Phase III MIRROR trial to evaluate MyoCell in up to 126 patients. Bioheart said FDA also placed a hold on its request for ...